DIPEPTIDYL-PEPTIDASE IV (DPP IV/CD26) AND INFLAMMATORY BOWEL DISEASE

被引：2
|
作者：
Pucar, Lara Baticic [1 ]
Detel, Dijana [1 ]
Varljen, Jadranka [1 ]
机构：
[1] Med Fak Sveucilista Rijeci, Zavod Kemiju & Biokemiju, HR-51000 Rijeka, Croatia
来源：
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY | 2012年 / 63卷 / 01期
关键词：
DEXTRAN SULFATE SODIUM; FIBROBLAST ACTIVATION PROTEIN; T-CELL-ACTIVATION; CHRONIC ULCERATIVE-COLITIS; GLUCAGON-LIKE PEPTIDE-2; NATURAL-KILLER-CELLS; CROHNS-DISEASE; ADENOSINE-DEAMINASE; MURINE COLITIS; CD26/DIPEPTIDYL-PEPTIDASE IV;
D O I：
10.2478/10004-1254-63-2012-2185
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：75 / 100
页数：26
相关论文
共 50 条
  • [31] Reduced susceptibility to EAE in CD26 (dipeptidyl-peptidase IV) deficient F344 rats
    von Hörsten, S
    Theil, MM
    Schween, J
    Bedoui, S
    Wedekind, D
    Pabst, R
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 72 - 72
  • [32] Kinetic study of the processing by dipeptidyl-peptidase IV/CD26 of neuropeptides involved in pancreatic insulin secretion
    Lambeir, AM
    Durinx, C
    Proost, P
    Van Damme, J
    Scharpé, S
    De Meester, I
    [J]. FEBS LETTERS, 2001, 507 (03): : 327 - 330
  • [33] MK-0431 -: Agent for type 2 diabetes dipeptidyl-peptidase IV (CD26) inhibitor
    Sorbera, LA
    Castañer, J
    [J]. DRUGS OF THE FUTURE, 2005, 30 (04) : 337 - 343
  • [34] Expression of CD26/dipeptidyl-peptidase IV in benign and malignant pigment-cell lesions of the skin
    Van den Oord, JJ
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1998, 138 (04) : 615 - 621
  • [35] Clinical relevance of the serum dipeptidyl peptidase IV DPP IV/CD26 activity in adult patients with Crohn's disease and ulcerative colitis
    Varljen, J
    Baticic, L
    Detel, D
    Varljen, N
    Sincic, BM
    [J]. FEBS JOURNAL, 2005, 272 : 492 - 492
  • [36] Clinical relevance of the serum dipeptidyl peptidase IV (DPP IV/CD26) activity in adult patients with Crohn's disease and ulcerative colitis
    Varljen, J
    Sincic, BM
    Baticic, L
    Varljen, N
    Detel, D
    Lekic, A
    [J]. CROATICA CHEMICA ACTA, 2005, 78 (03) : 427 - 432
  • [37] A prediction of DPP IV/CD26 domain structure from a physico-chemical investigation of dipeptidyl peptidase IV (CD26) from human seminal plasma
    Lambeir, AM
    Pereira, JFD
    Chacon, P
    Vermeulen, G
    Heremans, K
    Devreese, B
    VanBeeumen, J
    DeMeester, I
    Scharpe, S
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1997, 1340 (02): : 215 - 226
  • [38] CD26 (DIPEPTIDYL-PEPTIDASE-IV DPP-IV) AS A NOVEL MOLECULAR MARKER FOR DIFFERENTIATED THYROID-CARCINOMA
    TANAKA, T
    UMEKI, K
    YAMAMOTO, I
    SAKAMOTO, F
    NOGUCHI, S
    OHTAKI, S
    [J]. INTERNATIONAL JOURNAL OF CANCER, 1995, 64 (05) : 326 - 331
  • [39] Dipeptidyl Peptidase IV (DPP-IV, CD26) Levels In Patients With Rheumatoid Arthritis Treated With Biologic Therapies and Correlation With The Activity Of The Disease
    Pego-Reigosa, Jose M.
    Cordero, Oscar
    Lopez-Gonzalez, Tania
    Mourino-Rodriguez, Coral
    Aspe, Bruno
    Vinuela-Roldan, Juan
    Varela-Calvino, Ruben
    Calvino, Cristina
    Rodriguez-Lopez, Marina
    Hernandez-Rodriguez, Inigo
    del Campo-Perez, Victor
    [J]. ARTHRITIS AND RHEUMATISM, 2013, 65 : S591 - S592
  • [40] Dipeptidyl peptidase IV (CD26):: Role in T cell activation and autoimmune disease
    Reinhold, D
    Hemmer, B
    Gran, B
    Steinbrecher, A
    Brocke, S
    Kähne, T
    Wrenger, S
    Born, I
    Faust, J
    Neubert, K
    Martin, R
    Ansorge, S
    [J]. CELLULAR PEPTIDASES IN IMMUNE FUNCTIONS AND DISEASES 2, 2000, 477 : 155 - 160
12345